BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dincer N, Dagel T, Afsar B, Covic A, Ortiz A, Kanbay M. The effect of chronic kidney disease on lipid metabolism. Int Urol Nephrol 2019;51:265-77. [DOI: 10.1007/s11255-018-2047-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Luvizotto MJ, Menezes-silva L, Woronik V, Monteiro RC, Câmara NOS. Gut-kidney axis in IgA nephropathy: Role on mesangial cell metabolism and inflammation. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.993716] [Reference Citation Analysis]
2 Su D, Zhang X, He K, Chen Y, Wu N. Individualized prediction of chronic kidney disease for the elderly in longevity areas in China: Machine learning approaches. Front Public Health 2022;10:998549. [DOI: 10.3389/fpubh.2022.998549] [Reference Citation Analysis]
3 Banimfreg BH, Alshraideh H, Shamayleh A, Guella A, Semreen MH, Al Bataineh MT, Soares NC. Untargeted Metabolomic Plasma Profiling of Emirati Dialysis Patients with Diabetes versus Non-Diabetic: A Pilot Study. Biomolecules 2022;12:962. [DOI: 10.3390/biom12070962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Anvarifard P, Anbari M, Ostadrahimi A, Ardalan M, Ghoreishi Z. A comprehensive insight into the molecular and cellular mechanisms of the effects of Propolis on preserving renal function: a systematic review. Nutr Metab (Lond) 2022;19:6. [PMID: 35057819 DOI: 10.1186/s12986-021-00639-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zurita-cruz JN, Villasís-keever MÁ, Serret-montoya J, Barbosa-cortés L, Zepeda-martínez CDC, Alegría-torres G, Barradas-vázquez AS, Alonso-flores S, Hernández-hernández C, Manuel-apolinar L, Damasio-santana L, Domínguez-salgado JM. The leptin/adiponectin ratio as prognostic marker for dyslipidemia during 1 year of follow-up in pediatric patients receiving kidney replacement therapy. Nutr Hosp 2022. [DOI: 10.20960/nh.03890] [Reference Citation Analysis]
6 Noh HW, Jeon Y, Kim JH, Lee GY, Jeon SJ, Kim KY, Lim JH, Jung HY, Choi JY, Park SH, Kim CD, Kim YL, Cho JH. Higher Serum Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio Is Associated with Increased Mortality among Incident Peritoneal Dialysis Patients. Nutrients 2021;14:144. [PMID: 35011019 DOI: 10.3390/nu14010144] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Koshelskaya OA, Zhuravleva OA, Kologrivova IV, Margolis NY. Association of decreased glomerular filtration rate with renal hemodynamic disorders and inflammatory biomarkers in patients with medically-controlled hypertension of high cardiovascular risk. Russ J Cardiol 2021;26:4640. [DOI: 10.15829/1560-4071-2021-4640] [Reference Citation Analysis]
8 Fincher JA, Djambazova KV, Klein DR, Dufresne M, Migas LG, Van de Plas R, Caprioli RM, Spraggins JM. Molecular Mapping of Neutral Lipids Using Silicon Nanopost Arrays and TIMS Imaging Mass Spectrometry. J Am Soc Mass Spectrom 2021;32:2519-27. [PMID: 34435768 DOI: 10.1021/jasms.1c00159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Savira F, Magaye R, Scullino CV, Flynn BL, Pitson SM, Anderson D, Creek DJ, Hua Y, Xiong X, Huang L, Liew D, Reid C, Kaye D, Kompa AR, Wang BH. Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition. Toxicol Lett 2021;350:133-42. [PMID: 34303789 DOI: 10.1016/j.toxlet.2021.07.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ren L, Guo HN, Yang J, Guo XY, Wei YS, Yang Z. Dissecting Efficacy and Metabolic Characteristic Mechanism of Taxifolin on Renal Fibrosis by Multivariate Approach and Ultra-Performance Liquid Chromatography Coupled With Mass Spectrometry-Based Metabolomics Strategy. Front Pharmacol 2020;11:608511. [PMID: 33519473 DOI: 10.3389/fphar.2020.608511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
11 Yamaguchi Y, Zampino M, Moaddel R, Chen TK, Tian Q, Ferrucci L, Semba RD. Plasma metabolites associated with chronic kidney disease and renal function in adults from the Baltimore Longitudinal Study of Aging. Metabolomics 2021;17:9. [PMID: 33428023 DOI: 10.1007/s11306-020-01762-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
12 Vasylchenko VS, Korol LV, Kuchmenko OB, Stepanova NM; State Institution “Institute of Nephrology of the National Academy of Medical Sciences of Ukraine”, Kyiv, State Institution “Institute of Nephrology of the National Academy of Medical Sciences of Ukraine”, Kyiv;, National University of Kyiv-Mohyla Academy, Ukraine;, State Institution “Institute of Nephrology of the National Academy of Medical Sciences of Ukraine”, Kyiv;. The oxidative status in patients with chronic kidney disease. Ukr Biochem J 2020;92:70-7. [DOI: 10.15407/ubj92.05.070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Tao M, Wang HP, Sun J, Tian J. Progress of research on dyslipidemia accompanied by nephrotic syndrome. Chronic Dis Transl Med 2020;6:182-7. [PMID: 32885154 DOI: 10.1016/j.cdtm.2020.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Rayhan MA, Islam MK, Khatun MA, Islam D, Rahman MN. Remedial role of exercise training to deep-fried oil-induced metabolic and histological changes in Wistar rats. J Food Biochem 2020;44:e13458. [PMID: 32869884 DOI: 10.1111/jfbc.13458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Huang X, Jia Y, Zhu X, Zhang Y, Jiang L, Wei X, Zhao D, Zhao X, Du Y. Effects of Statins on Lipid Profile of Kidney Transplant Recipients: A Meta-Analysis of Randomized Controlled Trials. Biomed Res Int 2020;2020:9094543. [PMID: 32462035 DOI: 10.1155/2020/9094543] [Reference Citation Analysis]
16 Savira F, Magaye R, Liew D, Reid C, Kelly DJ, Kompa AR, Sangaralingham SJ, Burnett JC Jr, Kaye D, Wang BH. Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature. Br J Pharmacol 2020;177:2906-22. [PMID: 32250449 DOI: 10.1111/bph.15065] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]
17 Rodríguez FOR, Santiago JC, Jiménez GM, Carreño Rodríguez YR, Meléndez AR, Medina Uicab CJ, Salas LN, Quiñones Gamero MA, Ramírez CDRG, Covarrubias LG, Mendoza MS, Hernández Rivera JCH, Sierra RP. Post-Transplant Cholesterol and Triglyceride Behavior: Effects of Sex, Age of the Recipient, and Type of Donor. Transplantation Proceedings 2020;52:1157-62. [DOI: 10.1016/j.transproceed.2020.01.063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Huang X, Jia Y, Zhu X, Zhang Y, Jiang L, Wei X, Zhao D, Zhao X, Du Y. Effects of statins on lipid profile of kidney transplant recipients: a meta-analysis of randomized controlled trials.. [DOI: 10.1101/2020.04.07.20057349] [Reference Citation Analysis]
19 Kanbay M, Yerlikaya A, Sag AA, Ortiz A, Kuwabara M, Covic A, Wiecek A, Stenvinkel P, Afsar B. A journey from microenvironment to macroenvironment: the role of metaflammation and epigenetic changes in cardiorenal disease. Clin Kidney J 2019;12:861-70. [PMID: 31807301 DOI: 10.1093/ckj/sfz106] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
20 Valdivielso JM, Rodríguez-Puyol D, Pascual J, Barrios C, Bermúdez-López M, Sánchez-Niño MD, Pérez-Fernández M, Ortiz A. Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different? Arterioscler Thromb Vasc Biol 2019;39:1938-66. [PMID: 31412740 DOI: 10.1161/ATVBAHA.119.312705] [Cited by in Crossref: 88] [Cited by in F6Publishing: 96] [Article Influence: 29.3] [Reference Citation Analysis]
21 Schmit D, Fliser D, Speer T. Proprotein convertase subtilisin/kexin type 9 in kidney disease. Nephrology Dialysis Transplantation 2019;34:1266-71. [DOI: 10.1093/ndt/gfz122] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]